Lilly stomach-cancer drug helps survival, study finds
Eli Lilly and Co. shares rose nearly 5 percent Monday morning after it said a study found that its experimental stomach-cancer drug helped patients with advanced disease live longer.
Health Care & Life Sciences
Articles
Evans to lead AIT again as CEO leaves company
Ron Thieme, who took over as president and CEO of AIT Laboratories during a management shakeup earlier this year, is leaving the company, the Indianapolis-based firm announced Monday morning.
Can Lilly capitalize on Alzheimer’s breakthrough?
Eli Lilly and Co. has apparently made major medical history by being the first to develop a drug that alters the course of Alzheimer’s disease. But whether Lilly can be the first to make major money from a disease-altering Alzheimer’s drug is still in doubt.
WellPoint reorganizes into four business units
Separate Medicare and Medicaid divisions each will sell plans for those government-backed insurance programs. Another will handle commercial and individual business, and a specialty unit will provide dental, vision and disability coverage.
Small law firm sees faith in WellPoint class-action suit pay off
A federal judge in June granted preliminary approval to a deal under which WellPoint Inc. would pay $90 million to settle a lawsuit charging it undercompensated policyholders when it converted into a public company in 2001.
Lilly, Roche drugs chosen for Alzheimer’s prevention trial
Eli Lilly & Co.’s solanezumab and Roche Holding AG’s gantenerumab were selected for a long-term Alzheimer’s trial run by Washington University at St. Louis scientists seeking to block the disease’s symptoms.
Lilly shares rise on Alzheimer’s study results
Eli Lilly and Co.’s Alzheimer’s drug slowed cognitive decline 34 percent in patients with mild forms of the disease, according to an analysis of Lilly’s clinical trial data released Monday. Lilly’s share price jumped more than 5 percent on the news.
Study: Newly insured to be poorer, less educated
New health insurance coverage created by the 2010 health reform law will attract a lower-income, less-educated and more diverse set of customers than the insurance markets that exist today, according to a new analysis by PricewaterhouseCoopers. And that could create challenges for doctors and hospitals trying to care for those patients.
Lilly counting on diabetes products to challenge larger rivals
Eli Lilly and Co. is betting on a “broad” range of diabetes products including pills, insulins and a once-a-week treatment to take on bigger competitors, said Enrique Conterno, president of Lilly Diabetes.
Longtime insurance agency acquired by local rival
Property-casualty and employee benefits firm MJ Insurance buys Mead & Co., which dates to the 1860s.
St. Vincent, Community team up, forming colossus
Three area hospital groups—St. Vincent Health, Community Health Network and Suburban Health Organization—have agreed to join forces to manage patients’ health and strike new kinds of contracts with employers and health insurers.
Small charity eases struggles of breast cancer patients
With volunteer leader Nancy Shepard at the helm, IWIN Foundation has distributed $875,000 in grants to breast cancer patients. Recipients have ranged in age from 18 to 90.
New Alzheimer’s unit stresses soothing elements
The 36-room wing at Hoosier Village Retirement Center includes antiques and minimizes confusing shadows among other design elements.
Wellpoint raises $1.35B in first convertible offering since ’99
Indianapolis-based WellPoint Inc. sold its first convertible securities in more than 13 years with a $1.35 billion offering of 30-year bonds.
Amerigroup delays vote on $4.9B WellPoint acquisition
Amerigroup Corp. officials agreed to delay a shareholder vote on WellPoint Inc.’s $4.9 billion buyout offer to resolve investors’ claims they were being shortchanged in the deal, the company said in a securities filing.
WellPoint to add 100-plus local jobs for new Medicare contract
WellPoint Inc.’s National Government Services unit will add more than 100 jobs in Indianapolis beginning late this year or early next after the health insurance giant won a new contract with the federal Medicare program.
Dow Agro awarded $5.3M in patent-infringement case
The unsuccessful lawsuit filed by a subsidiary of Belgium-based Bayer Bioscience claimed that insect-resistant corn products from affiliates of Dow AgroSciences violated two of its patents.
Former IU Health exec joining Bose Public Affairs
Sam Odle, who retired from Indiana University Health in July as chief operating officer, is joining the local lobbying firm as a senior policy adviser, representing clients in the health care and life sciences sectors.
Sledge’s exit will keep IU program mostly intact
The departure of Dr. George Sledge likely will sap the breast cancer research program at the Indiana University Melvin and Bren Simon Cancer Center of about $500,000 in annual funding. But the program Sledge built over the past three decades mostly will remain intact.
Will Medicaid expansion actually work?
It would be “absurd” and a “travesty” for Indiana not to expand its Medicaid program, according to two local hospital officials. And yet other health care leaders do not expect expanded Medicaid coverage to provide nearly as much help to uninsured Hoosiers as hoped.